Literature DB >> 26062388

WHO Expert Committee on Drug Dependence. Thirty-sixth report.

.   

Abstract

This report presents the recommendations of the thirty-sixth WHO Expert Committee on Drug Dependence (ECDD). The ECDD is responsible for the assessment of therapeutic usefulness, the liability to abuse and dependence and the public health and social harm of each substance under review. After receiving the advice from the Expert Committee to schedule or to amend the scheduling status of a substance, the Director-General of WHO will as appropriate, communicate the recommendations to the United Nations. The report summarizes the review of 26 substances and the Committee's recommendations for scheduling under the international drug control conventions. The report also contains updates from international bodies concerned with controlled substances, a summary of the follow-up on recommendations made at the previous Committee meeting and a summary of the discussion on improving data collection and evidence for prioritization and substance evaluation, in particular for new psychoactive substances. Issues identified for consideration at future Expert Committee meetings are also listed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062388

Source DB:  PubMed          Journal:  World Health Organ Tech Rep Ser        ISSN: 0512-3054


  7 in total

1.  Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.

Authors:  Charles W Schindler; Eric B Thorndike; Steven R Goldberg; Kurt R Lehner; Nicholas V Cozzi; Simon D Brandt; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2015-08-29       Impact factor: 4.530

Review 2.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

3.  Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Authors:  Laurie S Anderson; Heidi G Bell; Michael Gilbert; Julie E Davidson; Christina Winter; Monica J Barratt; Beta Win; Jeffery L Painter; Christopher Menone; Jonathan Sayegh; Nabarun Dasgupta
Journal:  JMIR Public Health Surveill       Date:  2017-02-01

Review 4.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

5.  Common Opioids Involved in Drug Poisoning Presenting to the Emergency Department: A Cross-sectional Study.

Authors:  Nastaran Eizadi-Mood; Elham Haghshenas; Ali Mohammad Sabzghabaee; Ahmad Yaraghi; Ziba Farajzadegan
Journal:  J Res Pharm Pract       Date:  2021-01-11

6.  Differences in alcohol and cannabis use amongst substance use disorder patients with and without comorbid attention-deficit/hyperactivity disorder.

Authors:  Corné Coetzee; Ilse Truter; Anneke Meyer
Journal:  S Afr J Psychiatr       Date:  2022-04-14       Impact factor: 1.242

7.  Frequency of Electrocardiographic Abnormalities in Tramadol Poisoned Patients; a Brief Report.

Authors:  Anahita Alizadeh Ghamsari; Bita Dadpour; Fares Najari
Journal:  Emerg (Tehran)       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.